C. Thorne, D. Patel, and M. N. , Increased risk of adverse pregnancy outcomes in HIVinfected women treated with higly active antiretroviral therapy in Europe, AIDS, vol.18, issue.17, pp.2337-2376, 2004.

G. Woerner, I. Puch, K. Maier, R. Niehues, T. Notheis et al., Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women, HIV Medicine, vol.113, issue.(S, pp.6-13, 2008.
DOI : 10.1111/j.1468-1293.2008.00520.x

R. Tuomala, D. Shapiro, L. Mofenson, Y. Bryson, M. Culnane et al., Antiretroviral Therapy during Pregnancy and the Risk of an Adverse Outcome, New England Journal of Medicine, vol.346, issue.24, pp.1863-70, 2002.
DOI : 10.1056/NEJMoa991159

E. Szyld, E. Warley, L. Freimanis, R. Gonin, P. Cahn et al., Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth, AIDS, vol.20, issue.18, pp.2345-53, 2006.
DOI : 10.1097/01.aids.0000253362.01696.9d

A. Kourtis, C. Schmid, D. Jamieson, and J. Lau, Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis, AIDS, vol.21, issue.5, pp.607-622, 2007.
DOI : 10.1097/QAD.0b013e32802ef2f6

D. Patel, C. Thorne, M. Newell, . Response, and . Kourtis, Response to Kourtis et al. ???Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis???, AIDS, vol.21, issue.12, pp.1656-1663, 2007.
DOI : 10.1097/QAD.0b013e32826fb753

R. Masaba, R. Ndivo, I. Nyangau, K. Achola, C. Zeh et al., Comparison of Adverse Fetal Outcomes in HIV-1-infected Antiretroviral-naïve Pregnant Women Who Have Received Combivir and Either Nevirapine or Nelfinavir for Prevention of Mother-to-Child Transmission Antenatally (abstract 640), 15th Conference on Retroviruses and Opportunistic Infections, pp.3-6, 2008.

F. Dabis, L. Bequet, D. Ekouevi, I. Viho, C. Sakarovitch et al., Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission, AIDS, vol.19, issue.3, pp.309-327, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00193079

B. Tonwe-gold, D. Ekouevi, I. Viho, C. Amani-bosse, S. Toure et al., Antiretroviral Treatment and Prevention of Peripartum and Postnatal HIV Transmission in West Africa: Evaluation of a Two-Tiered Approach, PLoS Medicine, vol.346, issue.8, p.257, 2007.
DOI : 10.1371/journal.pmed.0040257.sd005
URL : https://hal.archives-ouvertes.fr/inserm-00170648

W. Fawzi, G. Msamanga, D. Spiegelman, E. Urassa, N. Mcgrath et al., Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania, The Lancet, vol.351, issue.9114, pp.1477-82, 1998.
DOI : 10.1016/S0140-6736(98)04197-X

F. Rouet, D. Ekouevi, M. Chaix, M. Burgard, A. Inwoley et al., Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting Impact of multiple births on low birthweight--Massachusetts, Morb Mortal Wkly Rep, pp.2709-17289, 1989.

C. Townsend, M. Cortina-borja, C. Peckham, and P. Tookey, Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland, AIDS, vol.21, issue.8, pp.1019-1045, 2007.
DOI : 10.1097/QAD.0b013e328133884b

. European-collaborative and . Study, Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women, J Acquir Immune Defic Syndr, vol.32, issue.4, pp.380-387, 2003.

A. Cotter, A. Garcia, M. Duthely, B. Luke, O. Sullivan et al., Is Antiretroviral Therapy during Pregnancy Associated with an Increased Risk of Preterm Delivery, Low Birth Weight, or Stillbirth?, The Journal of Infectious Diseases, vol.193, issue.9, pp.1195-201, 2006.
DOI : 10.1086/503045

R. Tuomala and S. Yawetz, Protease Inhibitor Use During Pregnancy: Is There an Obstetrical Risk?, The Journal of Infectious Diseases, vol.193, issue.9, pp.1191-1195, 2006.
DOI : 10.1086/503049

S. Fiore, M. Newell, D. Trabattoni, C. Thorne, L. Gray et al., Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women, Journal of Reproductive Immunology, vol.70, issue.1-2, pp.143-50, 2006.
DOI : 10.1016/j.jri.2005.12.001

K. Castetbon, J. Ladner, V. Leroy, M. Chauliac, E. Karita et al., Low birthweight in infants born to African HIV-infected women: relationship with maternal body weight during pregnancy, Journal of Tropical Pediatrics, vol.45, issue.3, pp.152-159, 1999.
DOI : 10.1093/tropej/45.3.152

J. Homsy, D. Moore, A. Barasa, C. Likicho, P. Behumbiize et al., Mother-tochild HIV transmission and infant mortality among women receiving highly active antiretroviral therapy (HAART) in rural Uganda (abstract TUPE0354) In: XVI International AIDS Conference, pp.13-18, 2006.